Improving immunovirotherapies: the intersection of mathematical modelling and experiments
Combined oncolytic virotherapy and immunotherapy (immunovirotherapy) protocols represent a promising treatment strategy for a range of cancers and offer many advantages over conventional anti-cancer therapies. Nevertheless, there are considerable challenges for this therapeutic modality, and clinica...
Saved in:
| Main Authors: | Christine E. Engeland, Johannes P.W. Heidbuechel, Robyn P. Araujo, Adrianne L. Jenner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-06-01
|
| Series: | ImmunoInformatics |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667119022000039 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical trials on oncolytic viruses
by: I. V. Golovinov, et al.
Published: (2025-01-01) -
Intratumoral/Peritumoral Herpes Simplex Virus-1 Mutant HSV1716 in Pediatric Patients with Refractory or Recurrent High-Grade Gliomas: A Report of the Pediatric Brain Tumor Consortium
by: Aaron Y. Mochizuki, et al.
Published: (2024-12-01) -
Comparative safety and efficacy of oncolytic virotherapy for the treatment of individuals with malignancies: a systematic review, meta-analysis, and Bayesian network meta-analysisResearch in context
by: Poyee Lau, et al.
Published: (2025-08-01) -
Correction: Experimental models for developing oncolytic virotherapy for metastatic prostate cancer
by: Ying-Cheng Chen, et al.
Published: (2025-08-01) -
A bibliometric analysis of oncolytic virotherapy combined with immunotherapy
by: Ting Zhang, et al.
Published: (2024-12-01)